Restrictions on the reimbursement of ginkgo biloba preparations to be eased

Standards for reimbursing ginkgo biloba preparations, such as SK Chemical’s Ginexin and Yuyu’s Tanamin, announced on January 1 are expected to be eased sometime next month, according to informed sources.

The public notice that the reimbursement of ginkgo biloba preparations would be limited to cognitive enhancement from this May is to be revised next month, according to the Health Insurance...